Angiopoietin-2 in Adults with Congenital Heart Disease and Heart Failure

Alexander Lukasz, Gernot Beutel, Philipp Kümpers, Agnieszka Denecke, Mechthild Westhoff-Bleck, Bernhard Schieffer, Johann Bauersachs, Jan T. Kielstein, Oktay Tutarel

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Background:Chronic heart failure is an important cause for morbidity and mortality in adults with congenital heart disease (ACHD). While NT-proBNP is an established biomarker for heart failure of non-congenital origin, its application in ACHD has limitations. The angiogenic factors Angiopoietin-1 and -2 (Ang-1, Ang-2), vascular endothelial growth factor (VEGF), and soluble receptor tyrosine kinase of the Tie family (sTie2) correlate with disease severity in heart failure of non-congenital origin. Their role in ACHD has not been studied.Methods:In 91 patients Ang-2 and NT-proBNP were measured and related to New York Heart Association class, systemic ventricular function and parameters of cardiopulmonary exercise testing. Ang-1, VEGF, and sTie2 were also measured.Results:Ang-2 correlates with NYHA class and ventricular dysfunction comparable to NT-proBNP. Further, Ang-2 showed a good correlation with parameters of cardiopulmonary exercise testing. Both, Ang-2 and NT-proBNP identified patients with severely limited cardiopulmonary exercise capacity. Additionally, Ang-2 is elevated in patients with a single ventricle physiology in contrast to NT-proBNP. VEGF, Ang-1, and sTie2 were not correlated with any clinical parameter.Conclusion:The performance of Ang-2 as a biomarker for heart failure in ACHD is comparable to NT-proBNP. Its significant elevation in patients with single ventricle physiology indicates potential in this patient group and warrants further studies.

Original languageEnglish
Article numbere66861
JournalPLoS ONE
Volume8
Issue number6
DOIs
StatePublished - 24 Jun 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Angiopoietin-2 in Adults with Congenital Heart Disease and Heart Failure'. Together they form a unique fingerprint.

Cite this